Literature DB >> 28579199

Comorbid Conditions in Canadians Hospitalized Because of Diabetes.

Andreas Wielgosz1, Sulan Dai2, Peter Walsh2, Jennifer McCrea-Logie2, Ece Celebican3.   

Abstract

OBJECTIVES: The number of hospital discharges involving type 1 or type 2 diabetes as the first-listed diagnosis has increased over the past few decades. Such cases are commonly associated with various comorbidities. We analyzed data collected from hospital separations in Canada to determine the number and proportion of comorbid conditions in Canadians hospitalized because of diabetes.
METHODS: The most responsible diagnosis (MRDx) of diabetes (ICD-10-CA: E10 [type 1 diabetes] or E11 [type 2 diabetes]) was identified from acute care hospital separations (Discharge Abstract Database) from 2013 to 2014 in all Canadian jurisdictions except Quebec. Hospital separations were calculated by 5-year age groups and sex. The most common comorbid (secondary) diagnoses were identified for hospital separations with diabetes as the MRDx, and the average lengths of stay associated with diabetes were determined.
RESULTS: The total number of hospital separations in 2013-2014 in Canada (excluding Quebec) with diabetes as the MRDx in all ages was 30,422, and males represented more than half (58.7%) of the separations. The median age group when diabetes is the MRDx is 60 to 64. For all patients hospitalized with an MRDx of diabetes, there were 2.2% deaths. Hypertension was the most common comorbid diagnosis in patients with diabetes as the MRDx, followed by glomerular disorders, peripheral angiopathy and acute renal failure.
CONCLUSIONS: Hospitalizations resulting from diabetes are associated with vascular comorbidities, and hypertension is the most common. Prevention of shared predisposing factors should reduce the burden of hospitalizations associated with diabetes. Crown
Copyright © 2017. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  comorbidities; comorbidités; diabetes; diabète; hospital; hypertension; hôpital; insuffisance rénale; renal failure

Mesh:

Year:  2017        PMID: 28579199     DOI: 10.1016/j.jcjd.2017.03.004

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN: 1499-2671            Impact factor:   4.190


  6 in total

1.  Comorbid Chronic Physical Illnesses in Type 1 Diabetes Adolescents: Personal, Caregiver, and Family Functioning.

Authors:  Demivette Gómez-Rivera; Eduardo Cumba-Avilés
Journal:  Salud Conducta Humana       Date:  2021-12-23

2.  Effective interventions to improve the quality of critically high point-of-care glucose meter results.

Authors:  Julie Lv Shaw; Christopher R McCudden; David A Colantonio; Ronald A Booth; Danny C Lin; Ivan M Blasutig; Thomas Moran; Dana Trofimczuk; Chantal Carriere; Anas Gharra; Cheryl Portelance; Chantal Tremblay; Dianne Dupaul; Nathalie Breton; Merina Angelkovski; Chetan Jariwala; Maureen Embleton; Christine Campbell; Kristina Groulx; Karen Larmour
Journal:  Pract Lab Med       Date:  2020-10-19

Review 3.  Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges.

Authors:  Jonathan D Chevinsky; Thomas A Wadden; Ariana M Chao
Journal:  Diabetes Metab Syndr Obes       Date:  2020-04-14       Impact factor: 3.168

4.  Individual and community-level income and the risk of diabetes rehospitalization among women and men: a Canadian population-based cohort study.

Authors:  Neeru Gupta; Dan L Crouse; Adele Balram
Journal:  BMC Public Health       Date:  2020-01-14       Impact factor: 3.295

5.  Association of diabetes with frequency and cost of hospital admissions: a retrospective cohort study.

Authors:  Jin Choi; Gillian Booth; Hae Young Jung; Lauren Lapointe-Shaw; Terence Tang; Janice L Kwan; Shail Rawal; Adina Weinerman; Amol Verma; Fahad Razak
Journal:  CMAJ Open       Date:  2021-04-16

Review 6.  Association of circulating cystatin C levels with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Cheng-Cheng Ma; Chun-Cui Duan; Rong-Cai Huang; Hai-Qin Tang
Journal:  Arch Med Sci       Date:  2019-03-11       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.